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ABSTRACT
One approach to investigating differences in the reported incidence of disease is to measure the extent of
exposure to the organism in question by testing for a speciﬁc antibody response. IgG responses to
Cryptosporidium sporozoite antigens of low molecular size in adults have been shown to be consistent
and of sufﬁcient intensity to act as reliable markers of exposure. This study used a western blot
procedure to investigate the relative intensity of IgG antibody responses to the 15 ⁄ 17-kDa Cryptospo-
ridium sporozoite antigen complex and the 27-kDa antigen in sera from two cities in north-west England:
Liverpool (low numbers of clinical cases reported) and Preston (high numbers reported). The intensity
of antibody response to the 15 ⁄ 17-kDa antigen complex was signiﬁcantly greater in the Liverpool sera,
but there was no signiﬁcant difference in intensity of response to the 27-kDa antigen. The relationship
between diagnosed and reported cryptosporidiosis infections and infections identiﬁed by serological
testing is complex, but could indicate a protective effect resulting from either exposure to non-
pathogenic strains or from repeated low-level exposure to pathogenic strains.
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INTRODUCTION
The protozoan parasite Cryptosporidium is distrib-
uted widely in the environment, and is a common
cause of gastrointestinal disease in humans [1].
Cryptosporidium infections can cause serious
morbidity and mortality in immunocompromised
patients, e.g., those living with AIDS [2], and
ill-health can persist for weeks after the acute
illness, even in immunocompetent patients [3].
Most reports concerning the epidemiology of
cryptosporidiosis have been concerned with out-
breaks of disease, particularly those caused by
drinking from piped water supplies [1,4]. How-
ever, recognised outbreaks represent only a small
proportion of cases of disease, and the majority of
cases reported are sporadic, in that they are not
linked to other known cases. Multiple sources and
routes of transmission contribute to a complex
epidemiological picture, and little is known about
the levels of endemic infection in the population.
Therefore, it cannot be assumed that the causes of
sporadic cryptosporidiosis are broadly the same
as those of outbreaks, or occur in roughly the
same proportion.
To date, there have been very few studies of
sporadic cryptosporidiosis. However, it would
appear that the incidence of cryptosporidiosis
varies quite markedly from one region to another,
and from one health authority to another within
the same region, suggesting that the epidemiol-
ogy of the disease also varies from one district to
another (within the UK, each health region is
made up of several health authority areas).
For example, the mean annual incidence of
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cryptosporidiosis in the north-west of England
between 1993 and 2002 was 12.0 cases ⁄
100 000 population, compared with 8.4 cases ⁄
100 000 population in England and Wales as a
whole (http://www.hpa.org.uk/infections/topics_
az/crypto/data_uk_geog2.htm). Within the north-
west region, the incidence varies substantially
from one health authority area to another, with
the incidence in north-west Lancashire during the
1990s being 17.4-fold greater than the incidence in
Liverpool [5].
Production of IgG antibodies to low molecu-
lar size Cryptosporidium sporozoite antigens in
adults has been shown to be consistent and of
sufﬁcient intensity to act as a reliable marker of
exposure, and correlates better than the results
of ELISA with known risk-factors for Cryptospo-
ridium infection [6]. The present study investi-
gated responses to the 15 ⁄ 17-kDa and 27-kDa
antigens; antibody responses to the former
appear to decline to baseline over a 4–6-month
period post-infection, representing a marker of
recent infection, while responses to the latter
remain for 6–12 months post-infection, provid-
ing a marker of slightly more distant infection
in terms of time [7]. Antibodies to these anti-
gens appear to be a reliable marker of exposure
to Cryptosporidium, at least in adults [8,9].
To ascertain the prevalence of exposure to
Cryptosporidium in two communities in the
north-west of England with marked differences
in the reported incidence of disease, a seropreva-
lence study was undertaken using a western blot
technique. The high-incidence city was Preston,
part of North-West Lancashire Health Authority,
and the low-incidence city was Liverpool. Further
sera were collected, where possible, from indi-
vidual patients to investigate the stability of
antibody levels over time.
MATERIALS AND METHODS
Sera
Anonymised paired serum samples, taken from adult patients
(aged ‡15 years), were collected from each of the two Public
Health Laboratories in Preston and Liverpool. The sera were
residual sera from samples submitted by local general prac-
titioners and local hospital trusts for a variety of clinical
reasons unrelated to Cryptosporidium infection, and were tested
with the approval of the relevant ethics committees. In order to
investigate the stability of test results over time, a second
(paired) serum was recovered from each patient, where
possible, after a gap of ‡4 months.
Serological tests
The sera were analysed for Cryptosporidium sporozoite
antibodies at the Cryptosporidium Reference Unit, Swansea,
using a western blot method described previously [10]. In
brief, a Cryptosporidium parvum sporozoite antigen prepara-
tion was made [11,12] from calf faeces infected with
C. parvum IOWA (also known as the Harley Moon isolate
[13]), and was separated into component antigen proteins
using SDS-PAGE mini-gel electrophoresis. The proteins were
then transferred by semi-dry transfer on to nitrocellulose
sheets, which were then placed in a multiscreen apparatus
that allows isolation of vertical strips of the blot for contact
with the test sera.
Test and control sera were prepared as 1:50 v ⁄v dilutions in
phosphate-buffered saline containing Tween-20 0.3% v ⁄v.
Bound human antibodies in the sera were detected by
incubation with a secondary biotinylated mouse anti-human
IgG antibody. The bound secondary antibody was then
detected using streptavidin–alkaline phosphatase, which was
visualised in a colourimetric reaction using 5-bromo-4-chloro-
3-indolyl phosphate as the substrate and nitroblue tetrazolium
as the chromagen [10]. Intensitometric data were obtained for
the serological responses to three sporozoite antigens: the
15-kDa and 17-kDa antigens which, since mini-gels do not
resolve the antigens separately, are hereafter referred to as the
15 ⁄ 17-kDa antigen complex [10], and the 27-kDa antigen, using
a digital camera and KDS1D analysis software (Kodak Digital
Science, Hemel Hempstead, UK). The relative intensity of each
antibody response was calculated as a percentage of that
obtained for the positive control on each blot. Data analysis
was performed using SPSS software (SPSS Inc., Chicago, IL,
USA).
Positive control serum from an acute laboratory-acquired
and conﬁrmed case of cryptosporidiosis caused by C. parvum
(IOWA) [14] was included on each blot. Inter-blot consistency
was achieved by reporting all intensities relative to the control
serum. Intra-blot consistency was assessed by probing four
entire blots with the positive control serum. The relative
intensity of each lane compared to the mean was determined,
and the overall variance in relative intensity was calculated
across all four blots. The variance ratios of the positive control
sera compared to the test sera were used to determine the
potential contribution of within-batch variation to variance in
the calculated sample intensities. In order to demonstrate a
dose–response between antibody quantity and the intensity of
the response, a doubling-dilution series of the positive control
was tested twice.
RESULTS
In total, 248 pairs of sera were collected from
Preston Public Health Laboratory (the high-inci-
dence area) between July 2000 and September
2002. Of the paired sera, 57 (23%) were from
males, 188 (76%) were from females, and the
gender was not known for three (1%). The age
range at the time of the ﬁrst specimen was
15–89 years (mean 36, median 32 years). The
mean time between collection of the ﬁrst and
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second serum samples was 344 days (range 109–
750 days, median 318 days).
In total, 84 pairs of sera and 152 single sera
were collected from Liverpool Public Health
Laboratory (the low-incidence area) between July
1995 and July 2000. Of the paired sera, 27 (32%)
were from males, 55 (65%) were from females,
and the gender was not known for two (2%). The
age range at the time of the ﬁrst specimen was
17–59 years (mean 33, median 31 years). The
mean time between collection of the ﬁrst and
second serum samples was 557 days (range
182–1356 days, median 473 days). Of the single
sera, 45 (30%) were from males, with an age range
of 19–73 years (mean 32, median 30 years).
Differences between the paired sera from Preston
and Liverpool in terms of the age of the donor at
the time of the ﬁrst sample were not signiﬁcant
(Mann–Whitney two-sample test z )1.853,
p 0.064); similarly, the gender distribution was
not signiﬁcantly different (uncorrected v2 3.425,
p 0.064).
For the ﬁrst or single sera, the mean relative
intensities of the 15 ⁄ 17-kDa and the 27-kDa
responses were 15.97 and 12.86 (variance 1478
and 585.7), respectively. This compares with
variance values of the positive control in the
intra-blot reproducibility studies of 0.1087 and
0.1126, respectively. The variance values of the
positive control sera were signiﬁcantly lower than
those of the test sera (15 ⁄ 17 kDa, F 13560,
p <0.0001; 27 kDa, F 5194, p <0.0001). Conse-
quently, uncertainty in the relative intensity
caused by test methodology would be minor
compared with natural variation in the test
sample intensity relative to the control. Fig. 1
shows the relationship between intensity and
dilution of the positive control, which demon-
strates an approximately linear log–log relation-
ship. The relative intensity of the response
obtained by this method is therefore a good
estimate of antibody levels.
There was a strong correlation between relative
intensity and the age of the donor for both the
anti-15 ⁄ 17-kDa antigen (Spearman’s rho 0.162,
p <0.0001) and the anti-27-kDa antigen (Spear-
man’s rho 0.134, p 0.003). The median relative
intensity of the 15 ⁄ 17-kDa antigen response was
signiﬁcantly higher in the sera from Liverpool
than in the sera from Preston (3.68 vs. 1.58; Mann–
Whitney U, p 0.044). Although the relative inten-
sities of the 27-kDa antigen response were also
higher in the Liverpool sera, this was not signif-
icant (median 5.04 vs. 3.68; Mann–Whitney U,
p 0.427).
When the analysis was restricted to the
paired sera only, the relative intensities of
antibody responses in the ﬁrst and second sera
from each individual, relative to the control
sera, were highly correlated for both the
15 ⁄ 17-kDa (Spearman’s rho 0.682, p <0.0001)
and the 27-kDa antigens (Spearman’s rho 0.750,
p <0.0001) (Fig. 2). However, there was a sig-
niﬁcant decline in the relative intensities of the
response in the second sera compared to the
ﬁrst sera for both the 15 ⁄ 17-kDa (p 0.0019) and
the 27-kDa antigens (Wilcoxon’s signed-rank
test, p 0.0108). Upon further analysis, this
decline was seen in the sera from Preston, but
not in the sera from Liverpool (for the 15 ⁄ 17-kDa
antigen, p 0.0136 vs. p 0.0829; for the 27-kDa
antigen, p 0.0002 vs. p 0.5546).
If seroconversion is deﬁned as an increase in
intensity by >10% of the intensity of the
positive control, then seroconversion was ob-
served in 27 (8%) of 332 sera according to the
15 ⁄ 17-kDa antigen response, and in 31 (9%) of
332 sera according to the 27-kDa antigen
response. Although the rate of seroconversion
was higher in the Liverpool sera for both
markers, this was a consequence of the longer
period between sample dates in the Liverpool
sera compared to the Preston sera. The conver-
sion rates ⁄ 100 person-years did not differ sig-
niﬁcantly for either marker between the two
populations.
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Fig. 1. Relationship between intensity of the antibody
response and dilution of the positive control serum.
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DISCUSSION
Cryptosporidium infection elicits an antibody
response in most exposed individuals, and the
western blot method is regarded as providing a
reliable measure of detecting Cryptosporidium
infection in sera from adult populations [6,8,9].
The mini-gel assay is a convenient format that
offers speciﬁcity of detection while maximising
the use of antigen preparations. The ﬁnding that
the relative intensity of the antibody response
to the 15 ⁄ 17-kDa antigen was more variable bet-
ween the ﬁrst and second samples than that to the
27-kDa antigen is consistent with results from
the USA, which revealed that the response to the
15 ⁄ 17-kDa antigen is short-lived (4–6 months),
while that to the 27-kDa sporozoite persists for up
to 2 years [7,10]. On the basis of these kinetics, it
would be expected that the relative intensity of
the response to the 27-kDa antigen would be
greater in randomly selected population sera than
the response to the 15 ⁄ 17-kDa antigen complex,
and this was found to be the case in the present
study, as well as in most, but not all, previous
studies.
Based on knowledge of the kinetics of antibody
responses, it might be expected that the preva-
lence of antibodies to the 27-kDa antigen would
also be greater in randomly selected population
sera than the response to the 15 ⁄ 17-kDa antigen
complex. Frost et al. [15] compared the antibody
responses to each antigen in blood donors from
two cities in the USA, and demonstrated that
positive serological responses (deﬁned as a band
intensity >10% that of the positive control) to the
27-kDa antigen were detected in more individuals
than were positive responses to the 15 ⁄ 17-kDa
antigen. Caputo et al. [16] reported similar results
from a cohort study of homosexual and bisexual
males with human immunodeﬁciency virus
infection, in that positive serological responses
(deﬁned as a band intensity >35% that of the
positive control) to the 27-kDa antigen were
found in more individuals than were positive
responses to the 15 ⁄ 17-kDa antigen. However, the
present study did not reveal a clear difference in
the prevalence of antibodies to these two
antigens, and this was similar to the observations
made by Frost et al. [17] in their study of a
cryptosporidiosis epidemic in Toronto, Canada.
The present study also found that the net intensity
of responses to the 27-kDa antigen was lower than
the response to the 15 ⁄ 17-kDa antigen (data not
shown), but Frost et al. [18] reported little differ-
ence between the intensity of each antibody
response in a study of serological responses
among users of surface and groundwater sources.
However, these ﬁndings may be associated with
the fact that the mini-gel western blot format
underestimates the 27-kDa response, particularly
at low levels [6].
Currently, there is no consensus concerning the
intensity of the positive antibody response
required to deﬁne Cryptosporidium seropositivity
in a western blot. Frost et al. [6] chose a cut-off
relative intensity value of 35% of the positive
control, citing evidence from paired sera collected
over an unspeciﬁed period that individuals may
maintain responses of £30% for extended periods
while responses >35% decline. Based on this
value, seroprevalence among blood donors was
22%, 26% and 48% for the 15-kDa, 17 k-Da and
27-kDa antigens, respectively. Using the same
cut-off value, a seroprevalence of 26% was
detected for the 15 ⁄ 17-kDa antigen complex and
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Fig. 2. Relative intensity of antibody responses to (a) the
15 ⁄ 17-kDa antigen complex and (b) the 27-kDa antigen in
paired sera from the north-west of England.
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of 39% for the 27-kDa antigen among homosexual
and bisexual males [16]. Other studies have used
cut-off values of >5% [17] and ‡1% [19] that of
the positive control to deﬁne a detectable
response. In some studies, blots have been
assessed by eye for any detectable antibody
response [9,20,21], which may equate to 5–10%
relative intensity, depending on the intensity of
the positive control. However, until further work
has deﬁned criteria for positive sera, focusing on
changes in the mean relative intensity of antibody
responses is perhaps a more useful approach for
analysis of data and generation of information
regarding population exposure to Cryptosporidium.
Moss et al. [9] explored changes in reactivity
using intensitometry, and concluded that increa-
ses in reactivity were more likely in experimen-
tally infected volunteers who were developing
cryptosporidiosis than in those who were infected
asymptomatically or who were oocyst-negative.
Variations in mean net intensity have also been
correlated with cases ⁄non-cases, in that symp-
tomatic infection was associated with consistent
changes in antibody responses [8]. Thus, relative
intensity is a useful measure for monitoring
exposure to Cryptosporidium at the population
level, and is a practical proxy for titration in the
western blot format.
Given the differences in the reported incidence
of cryptosporidiosis between Preston (high) and
Liverpool (low), it is interesting that there was no
signiﬁcant difference in intensity of response to
either the 15 ⁄ 17-kDa or the 27-kDa antigens,
indicating similar levels of exposure to Cryptos-
poridium. During the period of collection of the
sera, the mean annual number of reported cases
in Liverpool was 1.36 ⁄ 100 000 population, com-
pared with 23.43 ⁄ 100 000 population in Preston.
As reporting mechanisms are supposed to be
similar in the two locations [22], this ﬁnding is
difﬁcult to explain. One potential explanation is
that seropositivity may indicate infection caused
by species other than Cryptosporidium hominis or
C. parvum. Most other species are unlikely to
cause symptomatic illness, and it is known that
such species are quite widespread in the environ-
ment [23]. It is tempting to speculate that the
population of one city is exposed to a different
range of species, so that seroconversion is
detected in the absence of reportable illness after
exposure to non-pathogenic species of Cryptospo-
ridium. This suggestion is supported by a recent
study that showed similar antibody responses
following infections caused by Cryptosporidium
spp. that were and were not associated with
clinical symptoms [24]. Liverpool and Preston
both use drinking water from surface-derived
supplies, albeit from very different catchment
areas with different livestock densities. Water for
Preston (high levels of reported illness) is more
subject to contamination from cattle rather than
sheep, with the reverse situation being true for
Liverpool (low levels of reported illness), and it is
known that sheep may be colonised with a strain
that is demonstrated only rarely in human infec-
tions [25].
The present ﬁndings do not necessarily conﬂict
with an earlier study that reported higher anti-
body levels in a community following a recent
outbreak compared with an overall low incidence
reported in the area [26]. It is hypothesised that
residents in the low-incidence area in the present
study were subject to asymptomatic infection
through drinking water contaminated by non-
pathogenic species, but that the residents in the
low-risk area in the previous study were probably
not exposed in this way.
In the present study there was a correlation
between age and the increasing relative intensity
of the antibody response. However, this increase
with age probably reﬂects residual antibody
following multiple infections [27]. Two studies,
one in immunocompetent individuals and the
other in individuals infectedwith human immuno-
deﬁciency virus [28,29], have both demonstrated
that initial high levels of antibody to the 27-kDa
antigen were associated with a subsequent
reduced risk of self-reported diarrhoeal infection.
This suggests that cryptosporidiosis is responsible
for a considerably greater proportion of cases of
diarrhoea than thought previously, and that
repeated exposure may actually reduce the risk
of illness. This may explain the difference in
reporting rates between Liverpool and Preston.
A further interesting observation was the
decline in relative intensity in the second sample
compared with the ﬁrst samples in paired sera.
This was observed in sera from Preston, but not in
sera from Liverpool. It is tempting to suggest that
this reduction is associated with a reduction in the
incidence of cryptosporidiosis in the area second-
ary to the recent outbreak of foot and mouth
disease, or to the ‘Cryptosporidium in Drinking
Water Regulations’, which came into force in the
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UK during the collection of sera from Preston
[30,31].
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